N-MOmentum - study design for a placebo-controlled study of MEDI-551 in neuromyelitis optica

被引：0

作者：

Cree, B. A. C. ^{[1
]}

Bennett, J. L. ^{[2
]}

Hartung, H. -P. ^{[3
]}

Aktas, O. ^{[3
]}

Kim, H. J. ^{[4
,5
]}

Paul, F. ^{[6
]}

Pittock, S. ^{[7
]}

Weinshenker, B. ^{[7
]}

Wingerchuk, D. ^{[8
]}

Marignier, R. ^{[9
]}

Fujihara, K. ^{[10
]}

Cutter, G. ^{[11
]}

Flor, A. ^{[12
]}

Barron, G. ^{[13
]}

Patra, K. ^{[12
]}

Madani, S. ^{[12
]}

Katz, E. ^{[13
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Univ Colorado, Denver, CO 80202 USA

[3] Univ Dusseldorf, Dusseldorf, Germany

[4] Res Inst, Seoul, South Korea

[5] Natl Canc Ctr Hosp, Seoul, South Korea

[6] Charite, D-13353 Berlin, Germany

[7] Mayo Clin, Rochester, MN USA

[8] Mayo Clin, Scottsdale, AZ USA

[9] Lyon Univ Hosp, Lyon, France

[10] Tohoku Univ, Sendai, Miyagi 980, Japan

[11] Univ Alabama Birmingham, Birmingham, AL USA

[12] MedImmune, Gaithersburg, MD USA

[13] MedImmune, Cambridge, England

来源：

MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1349

引用

页码：705 / 706

页数：2

共 50 条

[41] Phase 2 open-label study of MEDI-551 and bendamustine versus rituximab and hendatoustine in adults with relapsed or refractory CLL.
Gladstone, Douglas Edward
Andre, Marc
Zaucha, Jan M.
Assouline, Sarit E.
Bellam, Naresh
Cascavilia, Nicola
Jourdan, Eric
Panwalkar, Amit W.
Patti, Caterina
Schulte, Clemens
Zaja, Francesco
Goswami, Trishna
Elgeioushi, Nairouz
Spaner, David
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[42] Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD
Cree, Bruce A. C.
Bennett, Jeffrey L.
Kim, Ho Jin
Weinshenker, Brian G.
Pittock, Sean J.
Wingerchuk, Dean
Fujihara, Kazuo
Paul, Friedemann
Cutter, Gary R.
Marignier, Romain
Green, Ari J.
Aktas, Orhan
Hartung, Hans-Peter
Williams, Ian M.
Drappa, Jorn
She, Dewei
Cimbora, Daniel
Rees, William
Ratchford, John N.
Katz, Eliezer
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (13) : 2052 - 2061
[43] Evaluation Of Infusion Reactions And Infusion Times In The N-Momentum Study Of Inebilizumab For NMOSD
Tullman, M.
Ratchford, J. N.
She, D.
Katz, E.
Cree, B. A.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 80 - 81
[44] Evaluation Of Infusion Reactions And Infusion Times In The N-Momentum Study Of Inebilizumab For NMOSD
Tullman, Mark
Ratchford, Jack
She, Dewei
Katz, Eliezer
Cree, Bruce
NEUROLOGY, 2021, 96 (15)
[45] Inebilizumab Reduces Worsening Of Disability In Neuromyelitis Optica Spectrum Disorder: Outcomes And Long-term Follow-up Data From The N-MOmentum Trial
Wingerchuk, D.
Marignier, R.
Bennett, J. L.
Kim, H.
Weinshenker, B.
Pittock, S.
Fujihara, K.
Paul, F.
Cutter, G.
Green, A.
Aktas, O.
Hartung, H.
Lublin, F. D.
Mealy, M. A.
Drappa, J.
Barron, G.
Madani, S.
She, D.
Cimbora, D.
Rees, W.
Ratchford, J. N.
Katz, E.
Cree, B. A.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 106 - 106
[46] Efficacy of satralizumab in subgroups of patients in SAkuraSky: A phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD)
Yamamura, T.
Kleiter, I.
Fujihara, K.
Palace, J.
Greenberg, J.
Zakrzewska-Pniewska, B.
Patti, F.
Tsai, C. P.
Saiz, A.
Haramura, M.
Terada, Y.
Kawata, Y.
De Seze, J.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
[47] A PLACEBO-CONTROLLED AND IMIPRAMINE-CONTROLLED STUDY OF PAROXETINE
COHN, JB
CROWDER, JE
WILCOX, CS
RYAN, PJ
PSYCHOPHARMACOLOGY BULLETIN, 1990, 26 (02) : 185 - 189
[48] PLACEBO-CONTROLLED STUDY OF PYRITINOL (ENCEPHABOL) IN DEMENTIA
COOPER, AJ
MAGNUS, RV
PHARMATHERAPEUTICA, 1980, 2 (05) : 317 - 322
[49] PLACEBO-CONTROLLED STUDY OF MIANSERIN IN DEPRESSED OUTPATIENTS
MCGRATH, PJ
RABKIN, JG
STEWART, JW
HARRISON, W
QUITKIN, FM
MARKOWITZ, J
NEUROPSYCHOBIOLOGY, 1985, 14 (03) : 128 - 132
[50] ACUPUNCTURE IN THE MANAGEMENT OF TINNITUS - A PLACEBO-CONTROLLED STUDY
AXELSSON, A
ANDERSSON, S
GU, LD
AUDIOLOGY, 1994, 33 (06): : 351 - 360

← 1 2 3 4 5 →